AzTrials
AzTrials

MeditationNCT07165795

Pilot Study to Evaluate the Effect of Transcendental Meditation on Telomere Activity and Well-Being Among Nurse Managers

A study testing Transcendental Meditation in people with Meditation, run by Sarasota Memorial Health Care System at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The objective of this study is to evaluate the impact of a health and coping strategy (Transcendental Meditation, or TM) on Telomere Length and Telomerase Activity (known markers of physiological and psychological stress and aging), Perceived Stress, Work Life Balance, Flourishing, Power as Knowing Participation in… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Meditation
What is being tested?
Transcendental Meditation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited States
Study dates
18 May 2025to May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Nurse managers within the Sarasota Memorial Health Care System (SMHCS);
  • Stable for at least two months on any prescribed medications (for example, anti-anxiety or anti-depressant medications)

Who cannot join

  • prior instruction in the TM technique

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • Sarasota Memorial Health Care System

    Sarasota, Florida, 34239

Other trials in United States

About this study

The objective of this study is to evaluate the impact of a health and coping strategy (Transcendental Meditation, or TM) on Telomere Length and Telomerase Activity (known markers of physiological and psychological stress and aging), Perceived Stress, Work Life Balance, Flourishing, Power as Knowing Participation in Change, and Burnout, among nurse managers.

Aim 1: To evaluate the effects of TM compared to usual care delayed instruction on TL and TA.

Aim 2: To evaluate the effects of TM compared to usual care delayed instruction on work life climate, flourishing, perceived stress, burnout, and power as knowing participation in change.

Conditions
Meditation
Being tested
Transcendental Meditation
Keywords
nurse manager, well-being, telomere, meditation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transcendental MeditationBehavioural

    Standard TM instruction by certified TM teachers, including 4 days of initial training (60-90 min/day), then follow-up sessions (60-90 min) every 2-4 weeks.

Study groups in NCT07165795
Study groupRoleWhat they receive
Immediate TM InstructionExperimentalThis group will receive initial TM instruction within three weeks of baseline assessments with follow-up interventions every 2-4 weeks and an expectation of home practice of two 20min meditation sessions per day.
Receives: Behavioral: Transcendental Meditation
Control Group (delayed instruction)No interventionThis group will be eligible to receive TM instruction upon completion of the final 4-month assessments, and asked to continue with routine activities throughout study.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Telomere Length

    T/S ratio; processed by UCSF Blackburn Labs SOP #104D

    Measured: baseline, 1-month, 4-months

  2. Telomerase Activity

    (# positive copies/10,000 input cells) ; processed by UCSF Blackburn Labs SOP #104D

    Measured: baseline, 1-month, 4-months

Secondary outcomes (5)
  1. Work-Life Climate Scale

    (Sexton, et al., 2017); measures work/life balance; responses range from 0-4; survey scores range 0-32, with lower scores reflecting better work/life balance.

    Measured: baseline, 1-month, 4-months

  2. Secure Flourishing Index, SFI

    (Weziak-Bialowolska et al., 2019); measures multidimensional well-being; survey scores range from 0-120, with higher scores reflecting a higher level of flourishing.

    Measured: baseline, 1-month, 4-months

  3. Perceived Stress Scale-10 (PSS10)

    (Cohen, 1988); measures the perception of stressful thoughts and feelings in preceding month; responses range from 0-40 with higher scores indicating higher levels of stress.

    Measured: baseline, 1-month, 4-months

  4. Maslach Burnout Inventory Human Services Survey for Medical Personnel

    (Maslach \& Jackson, 1984); Consists of three subscales: Emotional Exhaustion (9-items, score range 0-54, higher scores indicate more emotional exhaustion); Depersonalization (5-items, score range 0-18, higher scores indicate more depersonalization); and Personal Accomplishment (8-items, score range 0-48, higher scores indicate higher level of personal accomplishment).

    Measured: baseline, 1-month, 4-months

  5. Power as Knowing Participation in Change (PKPCT)

    Barrett (1983, 1984, 2010); Scores range from 48-336 in four subscales with higher scores indicating higher levels of perceived power.

    Measured: baseline, 1-month, 4-months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2025
  2. Study start18 May 2025
  3. Primary completionMay 2027 (estimated)
  4. Study completionMay 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study is a two-group randomized clinical trial (intervention and control groups) pilot study consisting of 30 nurse managers, with 15 nursing managers randomly assigned to each group.
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07165795
Sponsor's protocol ID
2288149-1
Status last verified
Sep 2025
First submitted
30 Jun 2025
Last updated
10 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Transcendental Meditation in people with Meditation, run by Sarasota Memorial Health Care System at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 10 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Telomere Length (time frame: baseline, 1-month, 4-months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in